AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01184365 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Energy Management Program
Description: The program content over the four sessions is structured as follows: Session 1 is an introduction to the group, important concepts, and upcoming session topics; Session 2 further elaborates on the concepts introduced in session 1 and encourages self-reflection; Session 3 is the peer to peer contact by phone or in person to assist with problems and share tips that really worked; and Session 4 concludes the program and serves to consolidate information learned.
Study NCT01184365 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Energy Management Program
Description: The goal of the EnMP-2 is to control for group effects
Study NCT02986542 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Femoral artery catheterization
Description: The intervention will be performed by a single experienced individual.
Study NCT00945464 — intervention group
Intervention type: OTHER
Intervention: Blood/saliva samples, historic breast imaging
Description: Subjects are required only to provide a blood or saliva sample, relevant personal and family history (if available), and 5 years of historic breast imaging reports.
Study NCT03785210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nivolumab
Description: 480 mg intravenous (IV) every 4 weeks
Study NCT03785210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tadalafil
Description: 10 mg by mouth (PO) daily
Study NCT01259362 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: 5 Hz, 120 % motor threshold, intertrain interval 20s, number of pulses in train 50.
Study NCT01259362 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Cocaine addicted will receive 20 sham TMSr
Study NCT02276560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Cisplatin, nab-paclitaxel
Description: Cisplatin (75mg/m2) D1, nab-paclitaxel 125 mg/m2) D1, 8, 15; repeat each 28 D cycle x 2 then surgery
Study NCT03664856 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interview
Description: The patient will be asked to answer the questions that the interviewer will ask him.
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Glucose Reference 1
Description: 50 g of glucose dissolved in 250 ml of water (First glucose control visit)
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Glucose Reference 2
Description: 50 g of glucose dissolved in 250 ml of water (Second glucose control visit)
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Glucose Reference 3
Description: 50 g of glucose dissolved in 250 ml of water (Third glucose control visit)
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brown Rice
Description: Unpolished brown rice containing 50 g of available carbohydrate was cooked using a rice cooker (Toyomi) at a ratio of rice to water of 1: 2
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3 % polished rice
Description: 3% polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6 % polished rice
Description: 6% polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 9 % polished rice
Description: 9 % polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2
Study NCT04228341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 20 % Polished rice
Description: White rice (20% polished rice), containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2.
Study NCT01664689 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microcoaxial Phacoemulsification
Study NCT02535819 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subluxation
Description: One pole of The nucleus is hydrodissected until it lilts above the capsular bag. The tilted nucleus is rotated to face the incision and remaining half nucleus is then tumbled and emulsification continues from the opposite equator outside in until complete
Study NCT02535819 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Divide and Conquer
Description: Cataract nucleus is fragmented into 4 pieces then aspirated by ultrasonic vibration
Study NCT02190461 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early Respiratory Rehabilitation Program
Study NCT02190461 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Respiratory Rehabilitation Program
Study NCT02114307 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: REVITIVE IX
Description: neuromuscular electrical stimulation device
Study NCT02114307 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: REVITIVE IX
Description: neuromuscular electrical stimulation device
Study NCT01091025 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Glucose profile for 2 weeks
Description: A study subject has an abnormal OGTT will be referred to a cystic fibrosis consultant who is not involved in the study.
Study NCT03775681 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Retrograde Cholangiopancreatography
Description: Undergo standard of care ERCP
Study NCT03775681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies
Study NCT03775681 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway
Description: Wear LMA
Study NCT03283709 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Full-contour monolithic zirconia abutment crowns
Description: Subjects with RPD abutment teeth that require surveyed crowns will have them fabricated from monolithic multi-layered zirconia
Study NCT03283709 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Conventional abutment crowns
Description: Subjects with RPD abutment teeth that require surveyed crowns will have them fabricated from noble or high noble metals, veneered with feldspathic porcelain
Study NCT04168541 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral Nutrition Supplement
Description: Product intake of oral nutrition supplement provided
Study NCT02084381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MCO-Ci 400
Description: hemodialysis
Study NCT02084381 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Revaclear 400
Description: hemodialysis
Study NCT01063530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DIammine SIlver fluoride
Description: Application of Diammine SIlver Fluoride in cervical lesions
Study NCT01063530 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: DIstilled water
Description: Application of distilled water in cervical lesions
Study NCT06219564 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Peripartum total abdominal hysterectomy (p-TAH)
Description: Peripartum total abdominal hysterectomy (cesarean hysterectomy) refers to a surgical procedure in which a woman undergoes both a cesarean section (C-section) and a hysterectomy simultaneously.~Placenta Accreta, Increta, or Percreta: These are conditions where the placenta attaches too deeply to the uterine wall. In cases of severe attachment, it may be difficult to remove the placenta without causing excessive bleeding, and a hysterectomy may be required.~Cesarean hysterectomy is a major surgical procedure involving significant medical expertise and coordination among healthcare professionals, including obstetricians and surgeons. The decision to perform a cesarean hysterectomy is usually made in emergency situations to address life-threatening complications.
Study NCT06219564 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cesarean Section (C/S)
Description: A cesarean section (C/S) involves making an incision in the abdominal wall and uterus to deliver a baby when a vaginal delivery is not feasible or safe.~Total placenta previa refers to a condition where the placenta completely covers the opening of the cervix in the uterus. This condition can pose significant risks during pregnancy and childbirth, and it often necessitates a planned cesarean section (C/S) for delivery.
Study NCT06219564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neonatal mortality
Description: Neonatal mortality refers to the death of a newborn within the first 28 days of life. This period is divided into early neonatal mortality, which covers the first seven days of life, and late neonatal mortality, which extends from the eighth to the 28th day. Neonatal mortality is a critical measure of the health and well-being of infants and is often used to assess a population's overall health and healthcare systems.~To reduce neonatal mortality, efforts are made to improve maternal healthcare, access to prenatal care, skilled attendance during childbirth, and the availability of neonatal healthcare services. Tracking and addressing factors contributing to neonatal mortality are crucial for improving the chances of survival of newborns and overall health outcomes.
Study NCT04517864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06651600
Description: 50 mg tablet, dosed as 200 mg QD or 50 mg QD 50 mg capsule, dosed as 50 mg QD
Study NCT04517864 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: tablet, dosed as 4 tablets QD or 1 tablet QD
Study NCT03912454 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous Bone Marrow Aspirate Concentrate (BMAC) Injection
Description: Subjects will undergo bone marrow aspiration from the iliac crest. Bone marrow will be concentrated and injected into the symptomatic lumbar disc.
Study NCT03409666 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taperloc Complete Microplasty stem
Description: Total hip replacement with Taperloc Complete Microplasty stem and G7 acetabular shell with E1 liner
Study NCT03409666 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Taperloc Complete Reduced Distal stem
Description: Total hip replacement with Taperloc Complete Reduced Distal stem and G7 acetabular shell with E1 liner
Study NCT02276560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adjuvant Cisplatin,nab-paclitaxel
Description: Cisplatin 75mg/m2 D1,nab-paclitaxel 125mg/m2 D1, 8, 15, repeat each 28D cycle x 2
Study NCT02276560 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine
Description: Cisplatin 75mg/m2 D1 + pemetrexed 500mg/m2 D1 or Gemcitabine 1000 mg/m2 D1, 8 (if SqCC) repeat each 21 D Cycle x 4
Study NCT01028547 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone
Description: single Bolus dose of dexamethasone 8mg
Study NCT01028547 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: 2 ml 0.9% saline
Study NCT01962077 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MedCem MTA pulpotomies in primary teeth.
Study NCT01875757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Study NCT01875757 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Study NCT01875757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT00512148 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous neobladder construct
Description: augmentation cystoplasty with autologous neo-bladder construct
Study NCT03673189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sensors
Description: Acquisition and transmission of exploitable recordings in the public targeted by the DS, that is to say which allow to draw clinical information in relation to the objectives of the DS (detection of the cardiac rhythm): data without artefact (saturation), in a good signal to noise ratio.
Study NCT04158856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: 400mg po every day
Study NCT04158856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Trastuzumab is administered at a loading dose of 8 mg/kg IV followed by 6 mg/kg every 21 days
Study NCT03967431 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Narrative Enhancement and Cognitive Therapy (NECT)
Description: Narrative Enhancement and Cognitive Therapy includes two introduction meetings, three psychoeducation meetings, seven cognitive restructuring meetings, seven narrative enhancement meetings and one summing up meeting.
Study NCT03040713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flortaucipir F18
Description: 370 megabecquerel (MBq)(10 millicurie \[mCi\]) injection, single dose
Study NCT04125004 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Samsung Virtual Reality Headset
Description: Patients will pick a game or feature from the virtual reality headset to use during their procedure
Study NCT01875757 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Study NCT06085469 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Temporal Adaptation Approach
Description: the temporal adaptation: It includes giving importance to the use of time, choosing meaningful activities, adjusting the time used during these activities and improving it. Such adaptation serves to improve an individual's quality of life, health, and occupational participation.
Study NCT02975986 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 123I-BMIPP
Description: Uptake of radioactive isotope by the kidney
Study NCT02975986 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 99mTc-MAG3
Description: Uptake of radioactive isotope by the kidney
Study NCT03083015 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: revascularization
Description: a sterile sharp needle was used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process
Study NCT03083015 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Apexification
Description: a 3-5 mm thickness of MTA using a hand plugger and was verified radiographically.
Study NCT03208478 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Adductor Canal perineural catheter placement
Description: Patients will receive an Adductor Canal Block intervention for pain control following ACL reconstructive surgeries.
Study NCT03208478 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Femoral Nerve perineural catheter placement
Description: Patients will have a Femoral perineural catheter placed for pain control following ACL reconstructive surgery.
Study NCT03208478 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nimbus pump (Infutronix)
Description: This is a FDA approved infusion device that is used in standard of care to store pain medication and to provide patients with continuous pain control medication at a set rate. This pump will be used for both the Adductor Canal and Femoral Nerve block participants.
Study NCT04099511 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care Occupational Therapy-Outpatient
Description: The control group in the proposed study will receive usual care occupational therapy services. The dosage between the experimental group and usual care will be identical with each group receiving ten 45- minute treatment sessions. The treating therapists will be unfamiliar with the experimental group intervention to avoid contamination. Each therapist will be instructed to provide care in the same manner as they typically provide in day-to-day practice for patients with similar characteristics as those in the study. The therapists will be encouraged to provide home action plans to participants. Usual care services will be monitored through a log of number of sessions, time spent in each session, and what activities were the focus of each session. The therapists will be instructed that they can address any participant goals they wish other than transfer goals identified by the participant.
Study NCT03040713 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Brain PET scan
Description: positron emission tomography (PET) scan of the brain
Study NCT03086304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcutaneous acupoint electrical stimulation
Description: Transcutaneous acupoint electrical stimulation is same to the traditional Chinese medicine acupuncture treatment,treat diseases by stimulate different acupuncture points.
Study NCT03086304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: no transcutaneous acupoint electrical stimulation
Description: the choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation.
Study NCT04325438 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmaceutical Care
Description: Pharmaceutical care interventions are categorised into 2 aspects:~1. Pharmacists' expertise aspect: medications review, identification and solution for the drug-related problem, adverse events, and other medication-related clinical problems. Therapeutic drug monitoring (TDM) is performed for any dose adjustment to the Rifampicin.~2. Motivational behavioral intervention to improve medication adherence (i.e. medications information and counseling to study participants).
Study NCT03983187 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rotating Magnetic Therapy
Description: Rotating Magnetic Therapy 30min/ Bid for 1 month
Study NCT04186780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shiitake cereal bar
Description: patients with borderline cholesterol exposed to bars with Shiitake
Study NCT04186780 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Shiitake cereal bar
Description: patients with borderline cholesterol exposed to bars with Shiitake
Study NCT02623322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MHAA4549A
Description: MHAA4549A will be administered as a single dose by IV administration.
Study NCT02623322 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a single dose by IV administration.
Study NCT00549757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aliskiren
Description: Aliskiren 150 mg film-coated tablets
Study NCT04099511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance
Description: The Cognitive Orientation to daily Occupational Performance (CO-OP) approach was developed within the field of occupational therapy and is a performance-based, problem-solving approach to address activity performance limitations. Subjects will be taught to use the global problem-solving strategy of Goal-Plan-Do-Check: identifying a specific goal (Goal), outlining a practical plan for reaching that goal (Plan), accurately performing the plan (Do), and analyzing whether the plan led to achievement of the goal and altering the plan accordingly (Check). The Goal-Plan-Do-Check process will be iteratively applied to each of the activity goals. Therapists will use guided discovery to allow the subject to self-identify their own potential solutions within an activity (develop the plan). The therapists will be instructed that they can address any participant goals they wish other than transfer goals identified by the participant.
Study NCT00549757 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match aliskiren 150 mg film-coated tablets
Study NCT04147039 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MINISTOP 2.0
Description: The MINISTOP 2.0 is a behavioural change program aiming to promote healthier diet and physical activity among 2.5-year-old children. The program consists of features such as information, monitoring and feedback (dietary key variables, physical activity, screen time) and it is built around 13 themes during the 6-month period.
Study NCT02313857 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Viralym-C
Description: Follow-up Assessments: The timing of follow-up visits is based on the date of Viralym-C infusion. If a patient has multiple Viralym-C infusions the schedule resets again at the beginning so follow up relates to the last Viralym-C infusion.~Follow up will occur at 7 days, 14 days, 21 days, 28 days, 35 days, 42 days, 90 days, 180 days, and 365 days post enrollment.
Study NCT03578796 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ECAS-N
Description: assessing ALS-specific cognitive impairment
Study NCT03578796 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MoCA
Description: assessing cognitive impairment
Study NCT03578796 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CDR
Description: assessing global cognitive impairment, as well as possible diagnosis- and Level of dementia
Study NCT03578796 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questions related to work situation and car driving
Study NCT01694732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Study NCT01694732 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT03376815 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: landscape sample method
Description: 200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .